Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Share-based Compensation: 2022-2024

Historic Share-based Compensation for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to $12.5 million.

  • Lexeo Therapeutics' Share-based Compensation rose 54.32% to $804,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $12.5 million for FY2024, which is 309.92% up from last year.
  • According to the latest figures from FY2024, Lexeo Therapeutics' Share-based Compensation is $12.5 million, which was up 309.92% from $3.0 million recorded in FY2023.
  • Lexeo Therapeutics' Share-based Compensation's 5-year high stood at $12.5 million during FY2024, with a 5-year trough of $1.8 million in FY2022.
  • For the 3-year period, Lexeo Therapeutics' Share-based Compensation averaged around $5.8 million, with its median value being $3.0 million (2023).
  • Data for Lexeo Therapeutics' Share-based Compensation shows a peak YoY soared of 309.92% (in 2024) over the last 5 years.
  • Lexeo Therapeutics' Share-based Compensation (Yearly) stood at $1.8 million in 2022, then spiked by 70.86% to $3.0 million in 2023, then soared by 309.92% to $12.5 million in 2024.